NO812500L - Fremgangsmaate ved fremstilling av et blodkoagulasjonsfremmende preparat paa basis av humanproteiner - Google Patents

Fremgangsmaate ved fremstilling av et blodkoagulasjonsfremmende preparat paa basis av humanproteiner

Info

Publication number
NO812500L
NO812500L NO812500A NO812500A NO812500L NO 812500 L NO812500 L NO 812500L NO 812500 A NO812500 A NO 812500A NO 812500 A NO812500 A NO 812500A NO 812500 L NO812500 L NO 812500L
Authority
NO
Norway
Prior art keywords
cogulation
promoting
blood
procedure
basis
Prior art date
Application number
NO812500A
Other languages
English (en)
Other versions
NO157245C (no
NO157245B (no
Inventor
Johann Eibl
Otto Schwarz
Fritz Elsinger
Anton Philapitsch
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of NO812500L publication Critical patent/NO812500L/no
Publication of NO157245B publication Critical patent/NO157245B/no
Publication of NO157245C publication Critical patent/NO157245C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO812500A 1980-07-22 1981-07-21 Fremgangsmaate ved fremstilling av et blodkoagulasjonsfremmende preparat paa basis av humanproteiner. NO157245C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0378180A ATA378180A (de) 1980-07-22 1980-07-22 Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen

Publications (3)

Publication Number Publication Date
NO812500L true NO812500L (no) 1982-01-25
NO157245B NO157245B (no) 1987-11-09
NO157245C NO157245C (no) 1988-02-24

Family

ID=3555339

Family Applications (1)

Application Number Title Priority Date Filing Date
NO812500A NO157245C (no) 1980-07-22 1981-07-21 Fremgangsmaate ved fremstilling av et blodkoagulasjonsfremmende preparat paa basis av humanproteiner.

Country Status (17)

Country Link
US (1) US4395396A (no)
AR (1) AR227194A1 (no)
AT (2) ATA378180A (no)
BE (1) BE889640A (no)
CH (1) CH646061A5 (no)
DE (1) DE3127318A1 (no)
DK (1) DK155500C (no)
ES (1) ES504000A0 (no)
FI (1) FI77048C (no)
FR (1) FR2487199A1 (no)
GB (1) GB2080312B (no)
HU (1) HU188298B (no)
IT (1) IT1142032B (no)
LU (1) LU83499A1 (no)
NL (1) NL190268C (no)
NO (1) NO157245C (no)
SE (1) SE460174B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3473407D1 (en) * 1983-05-02 1988-09-22 Immuno Ag Method of inactivating pathogens
AT379510B (de) * 1983-05-20 1986-01-27 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf) -haeltigen praeparation
GB8403473D0 (en) * 1984-02-09 1984-03-14 Special Trustees For St Thomas Purification of factor viii
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US4710381A (en) * 1984-05-22 1987-12-01 The Blood Center Of Southeastern Wisconsin Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
DE3877529T2 (de) * 1987-10-23 1996-11-07 Centre Regional De Transfusion Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat und dessen therapeutische Verwendung.
FR2622108B1 (fr) * 1987-10-23 1990-03-02 Lille Transfusion Sanguine Preparation de concentres de proconvertine (facteur vii), de facteur antihemophilique b (facteur ix) et d'autres proteines plasmatiques, et leur utilisation therapeutique
DE3843126C3 (de) * 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
US5110907A (en) * 1989-08-01 1992-05-05 Alpha Therapeutic Corporation Factor viii complex purification using heparin affinity chromatography
AT395597B (de) * 1991-01-25 1993-01-25 Immuno Ag Reagens zur bestimmung von faktor viii-aktivitaet
DE69231401T2 (de) * 1991-03-01 2001-02-08 Rhone Poulenc Rorer Int Herstellung von faktor-ix
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
FR2711371B1 (fr) * 1993-10-18 1995-12-29 Aetsrn Procédé de préparation d'un concentré d'inter-alpha-trypsine inhibiteur à usage thérapeutique et concentré obtenu.
DE4416166C2 (de) * 1994-05-06 1997-11-20 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
DE59712322D1 (de) * 1996-03-20 2005-06-30 Baxter Ag Pharmazeutisches Präparat zur Behandlung von Blutgerinnungsstörungen
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
PT973544E (pt) 1997-04-08 2001-12-28 Baxter Ag Preparacao de complexo de protrombina imunotolerante
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
AT411997B (de) 1999-09-14 2004-08-26 Baxter Ag Faktor ix/faktor ixa aktivierende antikörper und antikörper-derivate
CA2425935C (en) 2000-11-07 2011-03-29 Cryolife, Inc. Expandable foam-like biomaterials and methods
EP1523327A1 (de) * 2002-07-23 2005-04-20 Bio-Products & Bio-Engineering Aktiengesellschaft Thrombingenerierfahige und thrombinhaltige pharmazeutische wirkstoffzubereitungen und arzneimittel
AU2003246448A1 (en) * 2002-07-23 2004-02-16 Bio-Products And Bio-Engineering Aktiengesellschaft Pharmaceutically active substance preparations and drugs that are capable of generating thrombin and/or that contain thrombin
US7297336B2 (en) 2003-09-12 2007-11-20 Baxter International Inc. Factor IXa specific antibodies displaying factor VIIIa like activity
US20140206844A1 (en) 2013-01-18 2014-07-24 Prothera Biologics Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material
RU2648517C1 (ru) * 2017-06-23 2018-03-26 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения Российской Федерации (ФГБУ ГНЦ Минздрава России) Способ получения лиофилизированного препарата активированного протромбинового комплекса, обладающего фактор viii-шунтирующей активностью

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1492108A1 (de) 1964-05-04 1969-10-02 Rohm & Haas Verfahren zur Entfernung von Viren aus Blut waehrend der Entnahme oder UEbertragung
DE2262520B2 (de) * 1972-12-20 1979-10-11 Cutter Laboratories Inc., Berkeley, Calif. (V.St.A.) Verfahren zur Herstellung eines lyophilisierten, lagerfähigen Konzentrats aus menschlichem Plasma
US4170590A (en) * 1974-12-14 1979-10-09 Biotest-Serum-Institut Gmbh Ion exchanger treatment of citrate-stabilized plasma
JPS52125609A (en) 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
US4081432A (en) 1977-07-25 1978-03-28 Monsanto Company Method of separating a Factor IX preparation from plasma using ethylene-maleic anhydride polymers
US4287180A (en) * 1980-01-28 1981-09-01 Baxter Travenol Laboratories, Inc. Method for treating blood clotting factor inhibitors
EP0044343B1 (en) * 1980-01-28 1984-08-22 Baxter Travenol Laboratories, Inc. Prothrombin-containing therapeutic compositions and methods of producing enzymatically active blood clotting factors from prothrombin-containing blood fractions
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them

Also Published As

Publication number Publication date
FR2487199B1 (no) 1984-11-16
SE8103759L (sv) 1982-01-23
DK155500B (da) 1989-04-17
AT368883B (de) 1982-11-25
FR2487199A1 (fr) 1982-01-29
NO157245C (no) 1988-02-24
NO157245B (no) 1987-11-09
GB2080312A (en) 1982-02-03
NL190268B (nl) 1993-08-02
HU188298B (en) 1986-03-28
ES8203610A1 (es) 1982-04-16
NL190268C (nl) 1994-01-03
DK318581A (da) 1982-01-23
ATA378180A (de) 1982-04-15
SE460174B (sv) 1989-09-18
ES504000A0 (es) 1982-04-16
DE3127318A1 (de) 1982-04-15
FI77048C (fi) 1989-01-10
AR227194A1 (es) 1982-09-30
FI812295L (fi) 1982-01-23
CH646061A5 (de) 1984-11-15
NL8103329A (nl) 1982-02-16
IT8123070A0 (it) 1981-07-22
US4395396A (en) 1983-07-26
DE3127318C2 (no) 1988-07-28
IT1142032B (it) 1986-10-08
LU83499A1 (de) 1981-10-29
GB2080312B (en) 1983-12-21
DK155500C (da) 1989-08-07
FI77048B (fi) 1988-09-30
BE889640A (fr) 1981-11-03

Similar Documents

Publication Publication Date Title
NO812500L (no) Fremgangsmaate ved fremstilling av et blodkoagulasjonsfremmende preparat paa basis av humanproteiner
RO86825A (ro) Procedeu pentru prepararea unor acizi 7-amino-3-metil-substituit -dela 3-cefem-4-carbo0ilici
PT86600A (pt) Process for the preparation of anticoagulant peptides
NO772978L (no) Fremgangsmaate ved fremstilling av et blodkoaguleringsfremmende preparat
NO814302L (no) Fremgangsmaate for fremstilling av et toert, vegetabilsk protein-isolat
NO810014L (no) Fremgangsmaate ved fremstilling av kikhostetoksoid
SE7910354L (sv) Medicinskt preparat
NO810675L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO884052D0 (no) Fremgangsmaate for fremstilling av et terapeutisk preparat.
NO814065L (no) Fremgansmaate for fremstilling av imidazolylfenylamidiner
NO167510C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer
NO814055L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive thienopyridinonderivater
DK427281A (da) Fremgangsmaade til fremstilling af terapeutiske praeparater
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
MX5938E (es) Procedimiento para la elaboracion de bizcochos ricos en proteinas
DK273585D0 (da) Fremgangsmaade til fremstilling af medicinske kosmetiske praeparater
NO148451C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive oximethere
AR225813A1 (es) Procedimiento para la preparacion de 3-picolina
IT1128163B (it) Procedimento per la preparazione di acidi alcanoici
IT1110819B (it) Procedimento per la preparazione di acidi benzen-carbossilici
NO812467L (no) Fremgangsmaate ved fremstilling av as-triazinderivater
NO155842C (no) Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider.
NO812937L (no) Fremgangsmaate ved fremstilling av terapeutisk virksomt n-(1-allyl-2-pyrrolidinyl-methyl)-2-methoxy-4-amino-5-methylsulfamoyl-benzamid
NO168581C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive beta-methylen-thiofenethanaminer
NO873571D0 (no) Fremgangsmaate for fremstilling av et terapeutisk virksomt preparat.